Stockholders' Equity -Schedule of Warrant Activity (Details) |
3 Months Ended |
---|---|
Mar. 31, 2021
$ / shares
shares
| |
Equity [Abstract] | |
Shares Underlying Warrants Outstanding, Beginning | shares | 3,501,014 |
Shares Underlying Warrants Granted | shares | 3,873,711 |
Shares Underlying Warrants Exercised | shares | (13,642) |
Shares Underlying Warrants Outstanding, Ending | shares | 7,361,083 |
Weighted Average Exercise Price Outstanding, Beginning | $ / shares | $ 8.03 |
Weighted Average Exercise Price Granted | $ / shares | 7.24 |
Weighted Average Exercise Price Exercised | $ / shares | 7.33 |
Weighted Average Exercise Price Outstanding, Ending | $ / shares | $ 7.62 |
Weighted Average Remaining Contractual Life, Beginning | 2 years 10 months 14 days |
Weighted Average Remaining Contractual Life, Ending | 2 years 6 months 25 days |
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights exercised. No definition available.
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights granted. No definition available.
|
X | ||||||||||
- Definition Number of warrants or rights exercised. No definition available.
|
X | ||||||||||
- Definition Number of warrants or rights granted. No definition available.
|
X | ||||||||||
- Definition Weighted Average Remaining Contractual Life, Beginning. No definition available.
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|